PRA Health Sciences, Inc

(NASDAQ:PRAH)

Latest On PRA Health Sciences, Inc (PRAH):

Date/Time Type Description Signal Details
2021-04-28 20:47 ESTNewsPRA Health Sciences EPS beats by $0.02, beats on revenueN/A
2021-04-16 00:43 ESTNewsSyneos Health gains following Thermo Fisher $17B deal for PPDN/A
2021-04-16 00:42 ESTNewsIcon wins U.S. antitrust approval for PRA Health acquisitionN/A
2021-04-15 06:43 ESTNewsPPD gains after report Thermo Fisher nearing $15B dealN/A
2021-04-13 18:51 ESTNewsPRA Health selected by Maryland State to supply remote patient monitoring servicesN/A
2021-04-07 20:19 ESTNewsPRA Health and Merck KGaA team up for human growth hormone treatment systemN/A
2021-04-01 21:53 ESTNewsWells Fargo upgrades ICON to overweight, sees ~20% upsideN/A
2021-03-09 12:17 ESTAnalyst RatingThe Analyst Target Price has increased from $147.4 to $149.33.Buy
2021-03-06 00:59 ESTNewsIcon upped to hold from sell at CFRA citing recent underperformanceN/A
2021-03-03 12:17 ESTAnalyst RatingThe Analyst Target Price has increased from $144.7 to $147.4.Buy
2021-03-01 12:12 ESTAnalyst RatingThe Analyst Target Price has increased from $139.4 to $144.7.Neutral
2021-02-27 00:27 ESTNewsPRA Health Sciences, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-02-26 16:11 ESTAnalyst RatingThe Analyst Target Price has increased from $127.42 to $139.4.Neutral
2021-02-25 21:46 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 14:18 ESTEarnings EstimateAn EPS average of $1.41 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-25 14:18 ESTEarnings EstimateAn EPS average of $6.62 is estimated for the 2022 year.Buy
2021-02-24 13:09 ESTNewsPRA Health Sciences EPS beats by $0.09, beats on revenueN/A
2021-02-24 13:09 ESTNewsICON to acquire PRA Health in a cash and stock deal valued at $12BN/A
2021-02-24 13:08 ESTNewsLabCorp sum-of-the-parts worth $313/share with activist push, analyst saysN/A
2021-02-24 13:08 ESTNewsWilliam Blair sees 'very complementary fit' with ICON acquisition of PRA HealthN/A
2021-01-27 08:18 ESTAnalyst RatingThe Analyst Target Price has increased from $126.75 to $127.42.Neutral
2021-01-21 12:33 ESTAnalyst RatingThe Analyst Target Price has increased from $125.5 to $126.75.Neutral
2021-01-13 08:25 ESTAnalyst RatingThe Analyst Target Price has increased from $125.17 to $125.5.Neutral
2021-01-11 12:28 ESTAnalyst RatingThe Analyst Target Price has increased from $124.75 to $125.17.Neutral
2021-01-08 12:25 ESTAnalyst RatingThe Analyst Target Price has increased from $122.92 to $124.75.Neutral
2020-12-03 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $122.77 to $122.92.Buy
2020-11-26 21:16 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 05:08 ESTAnalyst RatingThe Analyst Target Price has increased from $121.23 to $122.77.Buy
2020-11-11 04:45 ESTAnalyst RatingThe Analyst Target Price has increased from $119.62 to $121.23.Buy
2020-11-09 20:50 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 13:06 ESTAnalyst RatingThe Analyst Target Price has increased from $117.23 to $119.62.Buy
2020-11-08 00:39 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:52 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 14:59 ESTNewsPRA Health Sciences, Inc. 2020 Q3 - Results - Earnings Call PresentationN/A
2020-11-07 14:58 ESTNewsPRA Health Sciences, Inc. (PRAH) CEO Colin Shannon on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-06 12:32 ESTAnalyst RatingThe Analyst Target Price has increased from $114.38 to $117.23.Buy
2020-11-05 13:05 ESTNewsPRA Health Sciences EPS beats by $0.16, beats on revenue; FY20 guidanceN/A
2020-11-05 13:00 ESTEarnings EstimateAn EPS average of $1.27 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-05 12:59 ESTAnalyst RatingThe Analyst Target Price has increased from $113.77 to $114.38.Neutral
2020-10-30 14:20 ESTAnalyst RatingThe Analyst Target Price has increased from $113.46 to $113.77.Buy
2020-10-08 10:00 ESTAnalyst RatingThe Analyst Target Price has increased from $113.23 to $113.46.Buy
2020-10-06 09:50 ESTAnalyst RatingThe Analyst Target Price has decreased from $113.62 to $113.23.Neutral
2020-09-26 13:47 ESTFinancialsCompany financials have been released.Neutral
2020-09-22 05:57 ESTNewsPRA Health Sciences: A Solid Investment Case But Watch Out For Signs Of InertiaN/A
2020-09-18 14:53 ESTNewsPRA Health and Deep Lens partner to accelerate patient recruitmentN/A
2020-09-17 05:53 ESTFinancialsCompany financials have been released.Neutral
2020-09-16 17:43 ESTInsider TradeGlen D. Stettin has directly acquired 799 shares and currently holds 799 shares.Buy
2020-08-17 16:30 ESTInsider TradeMichael J. Bonello has directly disposed of 2,052 shares and currently holds 21,276 shares.Sell
2020-08-17 16:30 ESTInsider TradeChristopher L Gaenzle has directly disposed of 1,364 shares and currently holds 37,636 shares.Sell
2020-08-17 16:30 ESTInsider TradeCOLIN SHANNON has directly disposed of 6,073 shares and currently holds 56,927 shares.Sell

About PRA Health Sciences, Inc (PRAH):

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. It operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, as well as bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services that allow clients to access and analyze Symphony Health and integrated third-party data. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardiometabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.

PRAH Quotes by TradingView

See Advanced Chart

General

  • Name PRA Health Sciences, Inc
  • Symbol PRAH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Full Time Employees 18,100
  • Fiscal Year EndDecember
  • IPO Date2014-11-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryLife Sciences Tools & Services
  • Gic SubIndustryLife Sciences Tools & Services
  • Web URLhttp://prahs.com
View More

Valuation

  • Trailing PE 48.08
  • Forward PE 24.75
  • Price/Sales (Trailing 12 Mt.) 2.96
  • Price/Book (Most Recent Quarter) 6.35
  • Enterprise Value Revenue 3.25
  • Enterprise Value EBITDA 23.88
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $5.81
  • Next Year EPS Estimate $6.60
  • Next Quarter EPS Estimate $1.32
  • Profit Margin 6%
  • Operating Margin 9%
  • Return on Assets 5%
  • Return on Equity 15%
  • Revenue 3.18 billion
  • Earnings Per Share $3.04
  • Revenue Per Share $50.25
  • Gross Profit 1.53 billion
  • Quarterly Earnings Growth 9.1%
View More

Highlights

  • Market Capitalization 9.43 billion
  • EBITDA 415.57 million
  • PEG Ratio 1.85
  • Analyst Target Price $149.33
  • Book Value Per Share $22.92
View More

Share Statistics

  • Shares Outstanding 64.54 million
  • Shares Float 64.37 million
  • % Held by Insiders 24%
  • % Held by Institutions 98.91%
  • Shares Short 853901
  • Shares Short Prior Month 748886
  • Short Ratio 1.15
  • Short % of Float 2%
  • Short % of Shares Outstanding 1%
View More

Technicals

  • Beta 1.27
  • 52 Week High $150.82
  • 52 Week Low $58.67
  • 50 Day Moving Average 134.39
  • 200 Day Moving Average 118.07
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

PRA Health Sciences, Inc (PRAH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

PRA Health Sciences, Inc (PRAH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A$1.55$1.466.46%
2020-09-302020-11-04$796.28 million$1.30$1.1414.07%
2020-06-302020-08-06$N/A$0.86$0.824.5%
2020-03-312020-04-30$N/A$1.05$1.005.34%
2019-12-312020-02-20$800.24 million$1.54$1.474.63%
2019-09-302019-10-30$780.69 million$1.32$1.292.31%
2019-06-302019-07-31$763.31 million$1.22$1.174.09%
2019-03-312019-05-01$722.02 million$1.10$1.063.65%
2018-12-312019-02-27$729.65 million$1.31$1.273.28%
2018-09-302018-10-31$717.6 million$1.13$1.075.27%
2018-06-302018-08-01$722.84 million$1.00$0.955.35%
2018-03-312018-04-25$701.84 million$0.85$0.841.52%
2017-12-312018-02-21$655.9 million$1.04$1.021.49%
2017-09-302017-10-25$582.01 million$0.88$0.853.98%
2017-06-302017-08-07$533.72 million$0.79$0.746.54%
2017-03-312017-04-25$487.76 million$0.62$0.603.14%
2016-12-312017-02-22$472.39 million$0.71$0.6410.71%
2016-09-302016-11-02$453.26 million$0.64$0.630.87%
2016-06-302016-07-28$455.85 million$0.63$0.597.47%
2016-03-312016-04-27$430.22 million$0.55$0.533.79%
2015-12-312016-02-24$428.95 million$0.59$0.5017.02%
2015-09-302015-11-02$403.51 million$0.52$0.4515.56%
2015-06-302015-07-27$392.85 million$0.47$0.4017.5%
2015-03-312015-05-06$388.58 million$0.41$0.3132.26%
2014-12-312015-02-18$369.96 million$0.35$0.3016.67%

PRA Health Sciences, Inc (PRAH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

PRA Health Sciences, Inc (PRAH) Chart:

PRA Health Sciences, Inc (PRAH) News:

Below you will find a list of latest news for PRA Health Sciences, Inc (PRAH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

PRA Health Sciences, Inc (PRAH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

PRA Health Sciences, Inc (PRAH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920069440/0001104659-20-069440-index.htm
2018-10-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1613859/000000000018033979/0000000000-18-033979-index.htm
2018-11-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1613859/000000000018034843/0000000000-18-034843-index.htm
2019-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000008025519002969/0000080255-19-002969-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000008025520001277/0000080255-20-001277-index.htm
2018-02-01SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545718004721/0000215457-18-004721-index.htm
2018-06-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545718005685/0000215457-18-005685-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000021545719005002/0000215457-19-005002-index.htm
2019-12-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000083423719000382/0000834237-19-000382-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000083423720002824/0000834237-20-002824-index.htm
2020-01-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000090221920000201/0000902219-20-000201-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000093247118004056/0000932471-18-004056-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000093247119006033/0000932471-19-006033-index.htm
2018-04-20DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746918003013/0001047469-18-003013-index.htm
2018-08-07424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746918005435/0001047469-18-005435-index.htm
2018-08-08424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746918005508/0001047469-18-005508-index.htm
2019-03-06S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1613859/000104746919000948/0001047469-19-000948-index.htm
2019-04-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746919002379/0001047469-19-002379-index.htm
2019-09-04424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919004946/0001047469-19-004946-index.htm
2019-09-05424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919005017/0001047469-19-005017-index.htm
2019-09-13424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1613859/000104746919005229/0001047469-19-005229-index.htm
2020-04-03DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1613859/000104746920002068/0001047469-20-002068-index.htm
2017-11-01S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613859/000110465917065160/0001104659-17-065160-index.htm
2017-11-138-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917067943/0001104659-17-067943-index.htm
2017-11-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465917069448/0001104659-17-069448-index.htm
2017-12-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917074637/0001104659-17-074637-index.htm
2017-12-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465917075713/0001104659-17-075713-index.htm
2018-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2018-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2018-04-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918024903/0001104659-18-024903-index.htm
2018-04-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465918025621/0001104659-18-025621-index.htm
2018-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918026604/0001104659-18-026604-index.htm
2018-05-013Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918029351/0001104659-18-029351-index.htm
2018-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918029352/0001104659-18-029352-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037085/0001104659-18-037085-index.htm
2018-05-31S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037121/0001104659-18-037121-index.htm
2018-05-31S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918037123/0001104659-18-037123-index.htm
2018-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918038150/0001104659-18-038150-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042047/0001104659-18-042047-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042048/0001104659-18-042048-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042049/0001104659-18-042049-index.htm
2018-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918042050/0001104659-18-042050-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918050976/0001104659-18-050976-index.htm
2018-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000110465918052811/0001104659-18-052811-index.htm
2018-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465918052812/0001104659-18-052812-index.htm
2018-11-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1613859/000110465918066242/0001104659-18-066242-index.htm
2019-04-18DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465919022339/0001104659-19-022339-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034062/0001104659-19-034062-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034064/0001104659-19-034064-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034065/0001104659-19-034065-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919034066/0001104659-19-034066-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046055/0001104659-19-046055-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046966/0001104659-19-046966-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919046967/0001104659-19-046967-index.htm
2019-09-04FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1613859/000110465919048481/0001104659-19-048481-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920017131/0001104659-20-017131-index.htm
2020-03-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920029723/0001104659-20-029723-index.htm
2020-04-03DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1613859/000110465920043152/0001104659-20-043152-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920052387/0001104659-20-052387-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064309/0001104659-20-064309-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064310/0001104659-20-064310-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064311/0001104659-20-064311-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064312/0001104659-20-064312-index.htm
2020-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920064314/0001104659-20-064314-index.htm
2020-05-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920065894/0001104659-20-065894-index.htm
2020-05-26S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendmentshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920065895/0001104659-20-065895-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920069438/0001104659-20-069438-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920069439/0001104659-20-069439-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920069440/0001104659-20-069440-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920096108/0001104659-20-096108-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920096109/0001104659-20-096109-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920096111/0001104659-20-096111-index.htm
2020-09-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920105711/0001104659-20-105711-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000110465920105715/0001104659-20-105715-index.htm
2018-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118007240/0001140361-18-007240-index.htm
2018-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118030961/0001140361-18-030961-index.htm
2018-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118030997/0001140361-18-030997-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118036243/0001140361-18-036243-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036118036244/0001140361-18-036244-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119003050/0001140361-19-003050-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119016469/0001140361-19-016469-index.htm
2019-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1613859/000114036119016474/0001140361-19-016474-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114036120003236/0001140361-20-003236-index.htm
2019-10-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000114420419047874/0001144204-19-047874-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001013/0001410578-19-001013-index.htm
2019-09-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001086/0001410578-19-001086-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000141057819001235/0001410578-19-001235-index.htm
2018-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284818000354/0001422848-18-000354-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284819000095/0001422848-19-000095-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1613859/000142284820000079/0001422848-20-000079-index.htm
2018-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385918000005/0001613859-18-000005-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385918000007/0001613859-18-000007-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000006/0001613859-19-000006-index.htm
2019-02-2810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000008/0001613859-19-000008-index.htm
2019-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000014/0001613859-19-000014-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000016/0001613859-19-000016-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000018/0001613859-19-000018-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000022/0001613859-19-000022-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000025/0001613859-19-000025-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000028/0001613859-19-000028-index.htm
2019-10-3110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385919000031/0001613859-19-000031-index.htm
2019-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385919000035/0001613859-19-000035-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000004/0001613859-20-000004-index.htm
2020-02-2110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000007/0001613859-20-000007-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000010/0001613859-20-000010-index.htm
2020-05-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000012/0001613859-20-000012-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000014/0001613859-20-000014-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000018/0001613859-20-000018-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000020/0001613859-20-000020-index.htm
2020-09-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000025/0001613859-20-000025-index.htm
2020-11-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000161385920000030/0001613859-20-000030-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000161385920000032/0001613859-20-000032-index.htm
2018-02-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018001965/0001628280-18-001965-index.htm
2018-02-2210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1613859/000162828018002026/0001628280-18-002026-index.htm
2018-04-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018004985/0001628280-18-004985-index.htm
2018-04-2610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000162828018005099/0001628280-18-005099-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1613859/000162828018010186/0001628280-18-010186-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1613859/000162828018010277/0001628280-18-010277-index.htm

PRA Health Sciences, Inc (PRAH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PRA Health Sciences, Inc (PRAH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 24%
Institutional Ownership: 9891%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2017-12-28David W DockhornExecutive Vice President & CCOSell4,236.0091.22386,407.920.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOSell2,595.0090.56235,003.200.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2017-11-16Matthew P. YoungDirectorSell5,115.0079.90408,688.500.00https://www.sec.gov/Archives/edgar/data/1613859/000110465917069448/0001104659-17-069448-index.htm
2018-06-21Jeffrey T BarberDirectorBuy1,307.0011,719.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042048/0001104659-18-042048-index.htm
2019-06-03Jeffrey T BarberDirectorBuy1,436.0013,155.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034062/0001104659-19-034062-index.htm
2019-08-13JAMES C MOMTAZEEDirectorBuy1,443.001,443.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046055/0001104659-19-046055-index.htm
2020-05-18Jeffrey T BarberDirectorBuy1,324.0014,479.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064312/0001104659-20-064312-index.htm
2020-08-13Michael J. BonelloEVP & CFOSell2,052.00102.88211,109.7621,276.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920096108/0001104659-20-096108-index.htm
2020-04-27Michael J. BonelloEVP & CFOSell3,672.0087.97323,025.8423,328.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920052387/0001104659-20-052387-index.htm
2018-06-21Alexander George DickinsonDirectorBuy1,307.002,397.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042047/0001104659-18-042047-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOSell64,405.0090.265,813,195.302,595.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2019-08-13Michael J. BonelloEVP & CFOBuy9,000.0027,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046967/0001104659-19-046967-index.htm
2019-09-06Fund Holdings L.P. KKR10% Share HolderSell6,666,684.0097.41649,401,688.4429,300.00https://www.sec.gov/Archives/edgar/data/1613859/000114036119016474/0001140361-19-016474-index.htm
2019-09-06PRA Investors L.P. KKR10% Share HolderSell6,666,684.0097.41649,401,688.4429,300.00https://www.sec.gov/Archives/edgar/data/1613859/000114036119016469/0001140361-19-016469-index.htm
2018-08-16COLIN SHANNONPresident & CEOBuy30,000.0030,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918052812/0001104659-18-052812-index.htm
2020-05-18JAMES C MOMTAZEEDirectorBuy1,748.003,191.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064311/0001104659-20-064311-index.htm
2020-08-13Christopher L GaenzleEVP, CAO & General CounselSell1,364.00102.88140,328.3237,636.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920096109/0001104659-20-096109-index.htm
2019-06-03Alexander George DickinsonDirectorBuy1,436.003,833.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034064/0001104659-19-034064-index.htm
2018-06-21Matthew P. YoungDirectorBuy1,307.004,117.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042050/0001104659-18-042050-index.htm
2017-12-28David W DockhornExecutive Vice President & CCOSell68,614.0090.816,230,837.344,236.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2020-05-18Alexander George DickinsonDirectorBuy1,324.005,157.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064314/0001104659-20-064314-index.htm
2019-06-03Matthew P. YoungDirectorBuy1,436.005,553.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034065/0001104659-19-034065-index.htm
2020-08-13COLIN SHANNONPresident & CEOSell6,073.00102.88624,790.2456,927.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920096111/0001104659-20-096111-index.htm
2019-08-13COLIN SHANNONPresident & CEOBuy33,000.0063,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919046966/0001104659-19-046966-index.htm
2018-06-21Linda S GraisDirectorBuy1,307.006,673.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918042049/0001104659-18-042049-index.htm
2018-08-09Fund Holdings L.P. KKR10% Share HolderSell6,500,000.00101.01656,565,000.006,695,984.00https://www.sec.gov/Archives/edgar/data/1613859/000114036118036244/0001140361-18-036244-index.htm
2018-08-09PRA Investors L.P. KKR10% Share HolderSell6,500,000.00101.01656,565,000.006,695,984.00https://www.sec.gov/Archives/edgar/data/1613859/000114036118036243/0001140361-18-036243-index.htm
2018-01-16LINDA BADDOURExecutive VP & CFOBuy67,000.0011.73785,910.0067,000.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918002870/0001104659-18-002870-index.htm
2020-05-18Matthew P. YoungDirectorBuy1,324.006,877.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064309/0001104659-20-064309-index.htm
2017-12-28David W DockhornExecutive Vice President & CCOBuy72,850.0011.73854,530.5072,850.00https://www.sec.gov/Archives/edgar/data/1613859/000110465918000222/0001104659-18-000222-index.htm
2020-09-14Glen D. StettinDirectorBuy799.00799.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920105715/0001104659-20-105715-index.htm
2019-06-03Linda S GraisDirectorBuy1,436.008,109.00https://www.sec.gov/Archives/edgar/data/1613859/000110465919034066/0001104659-19-034066-index.htm
2020-05-18Linda S GraisDirectorBuy1,324.009,433.00https://www.sec.gov/Archives/edgar/data/1613859/000110465920064310/0001104659-20-064310-index.htm